opnurasib,jdq443,tislelizumab
novartis,beigene
['kontrast-01', 'jdq443', 'lung']
dr. maria de miguel gives an update on the kontrast-01 trial of the structurally unique kras g12c inhibitor jdq443 in the #asco23 #lungcancer oral session 
Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her